San Francisco, CA, February 1, 2026 — TheraNovex, a leader in clinical trial patient recruitment technology, today announced the launch of the industry’s first fully autonomous AI patient prescreening platform. This groundbreaking system operates independently without human intervention, marking a fundamental shift from "AI-assisted" tools to "AI-autonomous" recruitment operations.
The TheraNovex platform introduces specialized AI agents that execute the complete patient journey: conducting complex prescreening calls, managing email correspondence, scheduling appointments directly into coordinator calendars, and delivering multi-channel reminders. By automating these high-touch administrative tasks, the platform eliminates up to 90% of the manual burden currently placed on clinical research coordinators while maintaining a remarkable 95% prescreening accuracy rate.
Key Features of the Autonomous AI Platform
- Autonomous Email Communication: AI agents send personalized introduction emails, deliver study information packets, and provide eligibility results instantly. The system intelligently monitors engagement and triggers follow-up actions based on patient behavior.
- Self-Service Appointment Scheduling: Real-time synchronization with Google Calendar, Outlook, and major CTMS platforms allows patients to book enrollment appointments 24/7 without back-and-forth communication.
- Multi-Channel Reminder Sequences: A sophisticated, automated cadence of phone calls, SMS, and emails ensures patients remain engaged, reducing no-show rates through intelligent, two-way confirmation.
- Patient-Directed Callback Scheduling: Unlike human coordinators who may struggle with "phone tag," the AI agent asks patients for their preferred callback time and executes that call with 100% reliability at the exact minute requested.
- Context-Aware Continuity: The platform’s "Relay AI" ensures that every interaction—whether via email or phone—resumes exactly where the last one left off, referencing specific patient details like medication lists or previous health history.
How It Works: The Autonomous Workflow
The TheraNovex platform transforms a process that typically takes 2-3 hours of manual coordinator time into a seamless, zero-intervention experience. When a patient clicks a recruitment ad, the AI agent immediately sends a welcome email and eligibility screener. If the patient qualifies, the AI initiates a phone call within five minutes to conduct a deep-dive prescreening.
If a patient needs to gather more information, such as a medication list, the AI agent schedules a callback at the patient's convenience. Once fully qualified, the AI provides a personalized scheduling link, books the appointment into the site's calendar, and initiates a multi-touch reminder sequence (7 days, 3 days, 24 hours, and 2 hours before the visit). The coordinator simply meets a qualified, confirmed, and prepared patient on the day of the appointment.
Unprecedented Efficiency Benefits
Traditional recruitment workflows are plagued by delays, with manual responses often taking hours or days, leading to high patient drop-off rates. TheraNovex’s autonomous agents provide instant gratification and 24/7 availability. Statistics from early pilot programs indicate:
- 90% Reduction in coordinator administrative tasks.
- 95% Accuracy in clinical prescreening data compared to human counterparts.
- Zero Missed Callbacks, ensuring no potential participant is lost to follow-up.
- Real-time Calendar Optimization, grouping similar appointments to maximize site throughput.
"The clinical research industry has reached a breaking point with coordinator burnout and recruitment delays. By moving from AI-assisted tools to fully autonomous agents, we are giving hours of time back to site staff, allowing them to focus on patient care rather than scheduling logistics. This isn't just an improvement; it's a total reimagining of how patients enter clinical trials."
— CEO of TheraNovex
Compliance and Security
TheraNovex maintains a steadfast commitment to data integrity and patient privacy. The autonomous platform is fully HIPAA and GDPR compliant, utilizing enterprise-grade encryption for all communications. Jennifer Walsh, VP of Regulatory Affairs, notes that the system includes built-in escalations to human staff for complex medical questions, ensuring the highest standards of safety and regulatory adherence are met throughout the autonomous journey.
About TheraNovex
TheraNovex is a premier clinical trial recruitment company dedicated to accelerating the delivery of life-saving therapies through advanced technology. By combining deep clinical expertise with cutting-edge AI, TheraNovex helps pharmaceutical companies and research sites reach enrollment goals faster and more efficiently than traditional methods.
Media Contact
Sarah Thompson
VP of Clinical Operations, TheraNovex
Email: media@theranovex.com
Website: www.theranovex.com